SkyePharma grants Sanofi exclusive rights to Flutiform in Mexico, Central America and South America

Skyepharma plc

U.K. / Small-Cap Biopharma (<$1 billion)

$20.7m on 07/29/2011 [market cap]

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Sanofi

France / Large-Cap Biopharma (>=$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced